Related Experiment Video
Updated: Aug 1, 2026

Determination of the Relative Potency of an Anti-TNF Monoclonal Antibody (mAb) by Neutralizing TNF Using an In Vitro Bioanalytical Method
Published on: September 16, 2017
Failure to inhibit endotoxin-induced uveitis with antibodies that neutralize tumor necrosis factor
1Casey Eye Institute, Oregon Health Sciences University, Portland 97201.
Abstract:
Many of the effects of bacterial endotoxin are attributed to the cytokines that it induces. Tumor necrosis factor alpha (TNF alpha) may be responsible for many of the pathophysiologic effects of endotoxin because antibodies that neutralize TNF alpha reduce endotoxin-induced mortality in experimental animals and many of the activities of endotoxin can be mimicked by the infusion of TNF alpha. Accordingly, we tested the ability of an antibody that neutralizes TNF alpha in a well characterized rat model, endotoxin-induced uveitis. Rats receiving subcutaneous endotoxin had a prompt rise in serum TNF alpha that was eliminated by the monoclonal antibody. Small quantities of TNF alpha were detectable in aqueous humor after either subcutaneous or intravitreal injection of endotoxin. Endotoxin-induced uveitis as quantitated by cells and protein in aqueous humor was, however, not affected by the antibody. Similarly, intraocular inflammation was not reduced by the intravitreal injection of the neutralizing antibody. Although TNF alpha may mediate many of the systemic effects of endotoxin, its role in the intraocular inflammatory effects of endotoxin should be questioned.
Related Concept Videos
Tumor Immunotherapy
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

